Atlas Trials

KDR2-2 Suspension Eyedrop in the Treatment of Neovascular Glaucoma (KDR-NVG) Trial

Clinical trial NCT04844619 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04844619
Sponsor
Sun Yat-sen University
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Neovascular GlaucomaNeovascularization
Start date
2021-04-19
Primary completion
2024-12-31
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.